Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Helicobacter Pylori Infection in Sjögren’s Syndrome: Co-incidence or Causality?

Author(s): Massoud Saghafi, Nafiseh Abdolahi*, Reza Orang, Mohammad Reza Hatef and Mohammad Hadi Molseghi

Volume 15, Issue 3, 2019

Page: [238 - 241] Pages: 4

DOI: 10.2174/1573397114666181113102427

Price: $65

Abstract

Background and Aim: Lymphoid cell infiltration and destruction of exocrine glands, specifically lacrimal and salivary glands are characteristics of Sjogren’s syndrome (SS). An etiological role has been proposed for Helicobacter pylori (H. pylori), interacting in the clinical course and complications of SS (including gastric cancer and lymphoma). The aim of this study was to identify the probable correlation between H. pylori infection and Sjogren’s syndrome (SS).

Methods: In this case-control study, ELISA method was used to determine serum level of IgA and IgM anti H. pylori antibody in 43 subjects with SS according to the international criteria and 95 healthy subjects as control. SPSS-17 was used to analyze data with t-test. P value <0.05 were considered significant.

Results: Serum level of IgM (34.9% vs. 10.5%, p-value= 0.001) and IgA (67.4% vs. 46.3% p value= 0.021) anti H. pylori antibody were significantly higher in SS patients compared to the control group. There was a positive correlation between age and H. pylori infection (r=0.2, Pvalue= 0.05).

Conclusion: Patients with SS had a higher prevalence of H. pylori infection compared to the normal population. Eradication of H. pylori is recommended particularly in older patients with SS.

Keywords: Sjogren's syndrome, H. pylori, gastritis, lymphoma, co-incidence, causality.

« Previous Next »
Graphical Abstract

[1]
Theander E, Nilsson I, Manthorpe R, Jacobsson LT, Wadström T. Seroprevalence of Helicobacter pylori in primary Sjögren’s syndrome. Clin Exp Rheumatol 2001; 19(6): 633-8.
[PMID: 11791633]
[2]
Hasni SA. Role of Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol 2012; 24(4): 429-34.
[http://dx.doi.org/10.1097/BOR.0b013e3283542d0b] [PMID: 22617822]
[3]
Nishimura M, Miyajima S, Okada N. Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren’s Syndrome. J Dermatol 2000; 27(7): 450-2.
[http://dx.doi.org/10.1111/j.1346-8138.2000.tb02204.x] [PMID: 10935342]
[4]
Gasbarrini A, Franceschi F. Autoimmune diseases and Helicobacter pylori infection. Biomed Pharmacother 1999; 53(5-6): 223-6.
[http://dx.doi.org/10.1016/S0753-3322(99)80092-4] [PMID: 10424243]
[5]
Sorrentino D, Faller G, DeVita S, et al. Helicobacter pylori associated antigastric autoantibodies: role in Sjögren’s syndrome gastritis. Helicobacter 2004; 9(1): 46-53.
[http://dx.doi.org/10.1111/j.1083-4389.2004.00197.x] [PMID: 15156903]
[6]
De Vita S, Ferraccioli G, Avellini C, et al. Widespread clonal B-cell disorder in Sjögren’s syndrome predisposing to Helicobacter pylori-related gastric lymphoma. Gastroenterology 1996; 110(6): 1969-74.
[http://dx.doi.org/10.1053/gast.1996.v110.pm8964425] [PMID: 8964425]
[7]
Showji Y, Nozawa R, Sato K, Suzuki H. Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol 1996; 40(7): 499-503.
[http://dx.doi.org/10.1111/j.1348-0421.1996.tb01100.x] [PMID: 8865155]
[8]
El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren’s syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 2005; 72(2): 135-41.
[http://dx.doi.org/10.1016/j.jbspin.2004.04.005] [PMID: 15797493]
[9]
Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 2003; 102(3): 1012-8.
[http://dx.doi.org/10.1182/blood-2002-11-3502] [PMID: 12676782]
[10]
Aragona P, Magazzù G, Macchia G, et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren’s syndrome. J Rheumatol 1999; 26(6): 1306-11.
[PMID: 10381048]
[11]
Talebi Bezmin Abadi A. Helicobacter pylori: Emergence of a Superbug. Front Med (Lausanne) 2014; 1: 34.
[http://dx.doi.org/10.3389/fmed.2014.00034] [PMID: 25593908]
[12]
Radić M. Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases. World J Gastroenterol 2014; 20(36): 12839-46.
[http://dx.doi.org/10.3748/wjg.v20.i36.12839] [PMID: 25278681]
[13]
Li T-T, Qiu F, Wang Z-Q, Sun L, Wan J. Rare case of Helicobacter pylori-related gastric ulcer: malignancy or pseudomorphism? World J Gastroenterol 2013; 19(12): 2000-4.
[http://dx.doi.org/10.3748/wjg.v19.i12.2000] [PMID: 23569348]
[14]
Wang H-P, Zhu Y-L, Shao W. Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma. World J Gastroenterol 2013; 19(45): 8219-26.
[http://dx.doi.org/10.3748/wjg.v19.i45.8219] [PMID: 24363512]
[15]
Nakamura S, Matsumoto T, Kitazono T. Helicobacter pylori eradication for gastric MALT lymphoma Nihon Rinsho 2013; 71(8): 1424-8.
[PMID: 23967674]

Rights & Permissions Print Cite
Article Metrics
40
4
1
1
© 2024 Bentham Science Publishers | Privacy Policy